About Chelation Therapy and a National Studies
Nearly all men and women over the age of 45 suffer to some degree from the effects of hardening arteries. Actually a 30% narrowing of the arteries is considered "normal" at that age. However, a plaque can be "vulnerable" to leakage, which causes a sudden clot that totally blocks the artery. Most people do not realize that they have a problem until they develop chest pains, cramps in their legs when they walk or a heart attack.
WHO NEEDS CHELATION THERAPY?
When an EDTA solution is injected into the bloodstream, it surrounds calcium ions in the blood and quickly takes them with it through the kidneys into the urine. The body then mobilizes calcium, some of which comes from hardened arteries, joint linings and other stiffened tissues. This process may even stimulate new bone growth for those who have weak bones (osteoporosis). Reports in the literature show that EDTA may reduce clotting, improve cholesterol and lower blood pressure. It must be emphasized that these mechanisms are one way we think that the therapy works. The removal of toxic metals from the bodyis another mechanism that makes EDTA an effective treatment for vascular disease.
The theory is that as the hardened arteries get softer and more flexible, more blood passes through. Diagnostic tests in our office taken before and after chelation (such as doppler ultrasound) have shown that areas of impaired circulation are often improved or even restored to normal function with chelation therapy.
WHAT DOES EDTA ACTUALLY DO? WHAT IS CHELATION?
Chelation (pronounced "key-lay-shun") is a non-surgical treatment for heavy metal poisoning which may be effective in treating cases of poor circulation and hardening of the arteries. The therapy consists of a series of slow intravenous infusions of a synthetic amino acid (ethylene diamine tetracetic acid--EDTA), along with diet, exercise, and stress management.
WHAT IS EDTA?
EDTA is a preservative that is found in many foods. The Food and Drug Administration includes EDTA on its list of Generally Recognized As Safe Drug (GRAS list).
Since the 1940's, EDTA has been used in cases of heavy metal poisoning (such as lead intoxication in children who have eaten lead-based paint) to remove the harmful metals from the body. It was incidentally noted that some patients who also had hardened arteries and were being treated for metal toxicity seemed to respond with improvement in circulatory function, as well as lowered blood pressure. This "side-effect" of EDTA has led to its current use as a form of therapy for all sorts of circulatory problems. Since then, refinements in protocol have improved the treatment even more.
People associate things like loss of sharp vision and hearing, dizziness and loss of memory with "old age." The reason some of us seem to get older and more senile than others is often due to the amount of narrowing of the arteries that is present. Chelation might be a help that many need to overcome the debilitating effects that arteriosclerosis can have all over the body.
WHAT WAS DIFFERANT IN THE TRIAL TO ACCESS CHELATION THERPAY (TACT)?
If a cardiologist or family doctor is negative about chelation, we now have his/her type of evidence for effectiveness and safety. Chelation plus standard care helps prevent future cardiac events. It should be an option for all heart patients, and especially for all diabetics.
THE IMPACT OF TACT IN 2016
Intravenous EDTA Chelation Therapy has been used to treat vacular disease since the 1950's. Most of the research was very favorable, but we did not have a large, definitive clinical trial that proved its effectiveness. One study was negative initially, but later turned out to have postitive results. This occurred about the time that cardiac surgery was introduced. Conventional medicine turned its back on chelation and embraced a combination of multiple drugs and bypass surgery.
For Fifty years, conventional medicine actually ridiculed chelation and discouraged their patients even from participating in research on the therapy. Fortunately, many alterantive doctors continued with chelation because of its observed results. After a Congressional hearing, the National Institutes of Health (NIH) finally funded a major study on chelation conducted by reowned research cardiologist, Gervasio Lamas. 134 sites participated, including Celebration of Health Association and Dr. Chappell.
After 10 years, the study of 1708 patients was completed, and it showed statisitcally significant improvements for those who received chelation in addition to conventional cardiac care, compared to those who received just regular care. For diabetic patients, the death rate was reduced by fifty percent over 5 years, even though they were treated for only eighteen months.
These data were presented to the faculty of many prominent medical schools. They were very impressed. No other drug has had such study results. However, the consensus was that the study had to be replicated. TACT-2, studying only diabetic patients with documented coronary artery blockages (a previous heart attach is required), began enrolling patients in September 2016. The study will last for 5 years.
In the meantime if you are interested in chelation therapy, based on its current research, please contact COHA and arrange a free phone consult with Dr. Chappell. We believe it to be a wonderful therapy.
Saving A Million Hearts